Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Citation data:

Journal of immunology (Baltimore, Md. : 1950), ISSN: 1550-6606, Vol: 181, Issue: 4, Page: 2513-21

Publication Year:
2008
Usage 100
Abstract Views 99
Link-outs 1
Captures 27
Readers 27
Citations 47
Citation Indexes 47
Repository URL:
https://escholarship.umassmed.edu/gsbs_sp/1572
PMID:
18684942
DOI:
10.4049/jimmunol.181.4.2513
PMCID:
PMC2587295
Author(s):
Lucas, Julie Ann; Menke, Julia; Rabacal, Whitney A.; Schoen, Frederick J.; Sharpe, Arlene H.; Kelley, Vicki R.
Tags:
Immunology and Microbiology; Animals; Antigens, CD80; Antigens, CD95; Antigens, Surface; Apoptosis Regulatory Proteins; Autoimmune Diseases; Bone Marrow Transplantation; Female; Genetic Predisposition to Disease; Immunophenotyping; Lupus Erythematosus, Systemic; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mice, Knockout; Mice, Transgenic; Myocarditis; Peptides; Pneumonia; Radiation Chimera; Signal Transduction; Life Sciences; Medicine and Health Sciences
article description
MRL/MpJ-Fas(lpr) (MRL-Fas(lpr)) mice develop a spontaneous T cell and macrophage-dependent autoimmune disease that shares features with human lupus. Interactions via the programmed death 1/programmed death ligand 1 (PD-1/PD-L1) pathway down-regulate immune responses and provide a negative regulatory checkpoint in mediating tolerance and autoimmune disease. Therefore, we tested the hypothesis that the PD-1/PD-L1 pathway suppresses lupus nephritis and the systemic illness in MRL-Fas(lpr) mice. For this purpose, we compared kidney and systemic illness (lymph nodes, spleen, skin, lung, glands) in PD-L1 null (-/-) and PD-L1 intact (wild type, WT) MRL-Fas(lpr) mice. Unexpectedly, PD-L1(-/-);MRL-Fas(lpr) mice died as a result of autoimmune myocarditis and pneumonitis before developing renal disease or the systemic illness. Dense infiltrates, consisting of macrophage and T cells (CD8(+) > CD4(+)), were prominent throughout the heart (atria and ventricles) and localized specifically around vessels in the lung. In addition, once disease was evident, we detected heart specific autoantibodies in PD-L1(-/-);MRL-Fas(lpr) mice. This unique phenotype is dependent on MRL-specific background genes as PD-L1(-/-);MRL(+/+) mice lacking the Fas(lpr) mutation developed autoimmune myocarditis and pneumonitis. Notably, the transfer of PD-L1(-/-);MRL(+/+) bone marrow cells induced myocarditis and pneumonitis in WT;MRL(+/+) mice, despite a dramatic up-regulation of PD-L1 expression on endothelial cells in the heart and lung of WT;MRL(+/+) mice. Taken together, we suggest that PD-L1 expression is central to autoimmune heart and lung disease in lupus-susceptible (MRL) mice.